NCT00541814View on ClinicalTrials.gov

Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function

PHASE4UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2007

Study Completion Date

February 28, 2010

Conditions
Chronic Allograft Nephropathy
Interventions
DRUG

Cyclosporine

Target drug level 50-100 ng/ml or cyclosporine withdrawal

Trial Locations (1)

B15 2TH

RECRUITING

University Hospital Birmingham NHS Foundation Trust, Birmingham

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Hospital Birmingham

OTHER